Suppr超能文献

作为α-淀粉酶和α-葡萄糖苷酶抑制剂的四氢吡啶的多组分非对映选择性合成。

Multicomponent diastereoselective synthesis of tetrahydropyridines as α-amylase and α-glucosidase enzymes inhibitors.

作者信息

Saleem Faiza, Shamim Fariha, Özil Musa, Baltaş Nimet, Salar Uzma, Ashraf Sajda, Ul-Haq Zaheer, Taha Muhammad, Solangi Mehwish, Khan Khalid Mohammed

机构信息

HEJ Research Institute of Chemistry, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.

Department of Chemistry, Recep Tayyip Erdogan University, 53100, Rize, Turkey.

出版信息

Future Med Chem. 2023 Aug;15(15):1343-1368. doi: 10.4155/fmc-2023-0073. Epub 2023 Aug 31.

Abstract

Researchers seeking new drug candidates to treat diabetes mellitus have been exploring bioactive molecules found in nature, particularly tetrahydropyridines (THPs). A library of THPs () were synthesized via a one-pot multicomponent reaction and investigated for their inhibition potential against α-glucosidase and α-amylase enzymes. A nitrophenyl-substituted compound with IC values of 0.15 ± 0.01 and 1.10 ± 0.04 μM, and a value of 1.30 mg/ml was identified as the most significant α-glucosidase and α-amylase inhibitor, respectively. Kinetic studies revealed the competitive mode of inhibition, and docking studies revealed that compound binds to the enzyme by establishing hydrophobic and hydrophilic interactions and a salt bridge interaction with His279. These molecules may be a potential drug candidate for diabetes in the future.

摘要

寻求治疗糖尿病新药候选物的研究人员一直在探索自然界中发现的生物活性分子,特别是四氢吡啶(THPs)。通过一锅多组分反应合成了一个THPs文库,并研究了它们对α-葡萄糖苷酶和α-淀粉酶的抑制潜力。一种硝基苯基取代的化合物,其IC值分别为0.15±0.01和1.10±0.04μM,值为1.30mg/ml,分别被确定为最有效的α-葡萄糖苷酶和α-淀粉酶抑制剂。动力学研究揭示了抑制的竞争模式,对接研究表明化合物通过与His279建立疏水、亲水相互作用和盐桥相互作用与酶结合。这些分子未来可能成为治疗糖尿病的潜在药物候选物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验